Exiting new study from our lab suggest that CASP8 may serve as a biomarker for high-risk prostate cancer and potentially renal cancer. Congratulations Laura and team.
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
PreviousNew review article on the role of Trop2 in prostate cancer
NextExciting news: Dr. Manoj Kumar awarded Sanjiv Sam Gambhir – PHILIPS Fellowship in Precision Medicine (PHIND) for “Development of Trop2 Targeted PET-imaging Probe and Therapy for Cancer.” He is a Postdoctoral Research Fellow in Stoyanova Lab.